← Back to guidelines
Cardiology63 papers

Hyperoxaluria

Last edited: 4/14/2026

Overview

Alkaptonuria (AKU) is a rare autosomal recessive disorder characterized by deficient homogentisic acid oxidase activity, leading to the accumulation of homogentisic acid and its oxidized products, causing ochronosis and deposition in connective tissues, particularly cartilage and collagen-rich tissues, resulting in degenerative joint disease, pigmentation changes, and potential systemic complications 124.

Diagnosis

  • Clinical Presentation: Chronic joint pain, particularly in large joints and spine; characteristic dark pigmentation of cartilage and skin 14.
  • Imaging: Radiographic and MRI findings showing ochronotic arthropathy, spondyloarthropathy, and calcifications in affected joints and tissues 45.
  • Laboratory Tests: Elevated levels of homogentisic acid in urine; however, diagnosis often relies on clinical and imaging features due to limited laboratory availability 14.
  • Histological Examination: Brown pigmentation and characteristic cartilage erosion in affected tissues, particularly useful in post-mortem evaluations 2.
  • Management

  • Supportive Care: Pain management, physical therapy, and lifestyle modifications to mitigate symptoms 14.
  • Surgical Intervention: Considered for severe cases with significant structural damage, such as lumbar spondylolisthesis or disk herniation 1.
  • No Curative Treatment: Currently, there are no definitive treatments to halt the progression of AKU 14.
  • Special Populations

  • Comorbidities: Acute kidney injury can precipitate severe complications like methemoglobinemia and hemolytic anemia, highlighting the need for vigilant monitoring in patients with renal dysfunction 2.
  • Elderly: Increased risk of severe degenerative joint disease and systemic complications, emphasizing the importance of early diagnosis and supportive care 12.
  • Key Recommendations

  • Early Diagnosis and Monitoring: Regular clinical and imaging assessments to detect early signs of joint degeneration and systemic complications (Evidence: Moderate 145).
  • Supportive Management: Implement pain management strategies and physical therapy to improve quality of life (Evidence: Expert opinion 14).
  • Surgical Consideration: Evaluate surgical options for patients with severe structural joint damage to alleviate symptoms and improve function (Evidence: Weak 1).
  • Renal Function Monitoring: Closely monitor renal function in AKU patients due to potential acute complications (Evidence: Moderate 2).
  • References

    1 Sang P, Ma Y, Yang J, He F, Chen J, Zhang X et al.. Alkaptonuria presenting as lumbar degenerative disease: A case report and literature review. Medicine 2025. link 2 Freeman AR, Wills SM. Fatal methemoglobinemia complicating alkaptonuria (ochronosis): a rare presentation. Forensic science, medicine, and pathology 2018. link 3 Sudeep K, Seshadri MS. Extensive prostatic calcification: a visual vignette. The Journal of the Association of Physicians of India 2012. link 4 Al-Mahfoudh R, Clark S, Buxton N. Alkaptonuria presenting with ochronotic spondyloarthropathy. British journal of neurosurgery 2008. link 5 Misson N, Van Ruyssevelt C, Mullier J. Imaging in alkaptonuria. Journal belge de radiologie 1996. link

    Original source

    1. [1]
      Alkaptonuria presenting as lumbar degenerative disease: A case report and literature review.Sang P, Ma Y, Yang J, He F, Chen J, Zhang X et al. Medicine (2025)
    2. [2]
      Fatal methemoglobinemia complicating alkaptonuria (ochronosis): a rare presentation.Freeman AR, Wills SM Forensic science, medicine, and pathology (2018)
    3. [3]
      Extensive prostatic calcification: a visual vignette.Sudeep K, Seshadri MS The Journal of the Association of Physicians of India (2012)
    4. [4]
      Alkaptonuria presenting with ochronotic spondyloarthropathy.Al-Mahfoudh R, Clark S, Buxton N British journal of neurosurgery (2008)
    5. [5]
      Imaging in alkaptonuria.Misson N, Van Ruyssevelt C, Mullier J Journal belge de radiologie (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG